Citigroup’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$616K Sell
89,164
-63,327
-42% -$488K ﹤0.01% 3428
2025
Q4
$1.34M Buy
152,491
+125,883
+473% +$693K ﹤0.01% 2938
2025
Q3
$133K Sell
26,608
-853,995
-97% -$3.95M ﹤0.01% 4158
2025
Q2
$4.16M Buy
880,603
+484,113
+122% +$2.12M ﹤0.01% 2036
2025
Q1
$1.82M Buy
396,490
+338,867
+588% +$1.58M ﹤0.01% 2784
2024
Q4
$276K Sell
57,623
-11,881
-17% -$57K ﹤0.01% 4198
2024
Q3
$326K Buy
69,504
+54,434
+361% +$292K ﹤0.01% 4015
2024
Q2
$85.1K Buy
15,070
+3,327
+28% +$17.2K ﹤0.01% 4290
2024
Q1
$48.3K Buy
11,743
+2,483
+27% +$9.94K ﹤0.01% 4642
2023
Q4
$39.1K Buy
9,260
+7,947
+605% +$32.1K ﹤0.01% 4653
2023
Q3
$5.67K Sell
1,313
-113,307
-99% -$630K ﹤0.01% 4686
2023
Q2
$755K Sell
114,620
-107,230
-48% -$687K ﹤0.01% 3053
2023
Q1
$1.51M Buy
221,850
+113,816
+105% +$800K ﹤0.01% 2214
2022
Q4
$798K Sell
108,034
-51,885
-32% -$505K ﹤0.01% 2827
2022
Q3
$1.58M Buy
159,919
+42,440
+36% +$448K ﹤0.01% 2331
2022
Q2
$1.28M Buy
117,479
+35,095
+43% +$364K ﹤0.01% 2427
2022
Q1
$932K Sell
82,384
-69,490
-46% -$913K ﹤0.01% 3037
2021
Q4
$2.38M Buy
151,874
+58,518
+63% +$1.02M ﹤0.01% 2471
2021
Q3
$1.6M Sell
93,356
-45,560
-33% -$798K ﹤0.01% 2714
2021
Q2
$2.99M Sell
138,916
-54,020
-28% -$967K ﹤0.01% 2351
2021
Q1
$2.9M Buy
192,936
+176,334
+1,062% +$2.85M ﹤0.01% 2236
2020
Q4
$219K Buy
16,602
+10,435
+169% +$126K ﹤0.01% 4919
2020
Q3
$60K Sell
6,167
-52,776
-90% -$564K ﹤0.01% 5472
2020
Q2
$674K Buy
58,943
+16,203
+38% +$183K ﹤0.01% 3949
2020
Q1
$443K Buy
42,740
+13,450
+46% +$167K ﹤0.01% 3977
2019
Q4
$480K Sell
29,290
-99,214
-77% -$1.5M ﹤0.01% 4450
2019
Q3
$1.71M Buy
128,504
+10,860
+9% +$151K ﹤0.01% 3034
2019
Q2
$1.66M Buy
117,644
+59,826
+103% +$952K ﹤0.01% 3073
2019
Q1
$1.06M Sell
57,818
-19,985
-26% -$455K ﹤0.01% 3335
2018
Q4
$2.03M Buy
77,803
+24,511
+46% +$576K ﹤0.01% 2648
2018
Q3
$1.22M Buy
53,292
+51,007
+2,232% +$1.04M ﹤0.01% 3261
2018
Q2
$43K Buy
2,285
+560
+32% +$9.36K ﹤0.01% 6399
2018
Q1
$29K Sell
1,725
-87,146
-98% -$1.46M ﹤0.01% 6530
2017
Q4
$1.35M Sell
88,871
-39,182
-31% -$582K ﹤0.01% 3035
2017
Q3
$2.29M Buy
128,053
+81,490
+175% +$1.36M ﹤0.01% 2517
2017
Q2
$759K Buy
46,563
+14,063
+43% +$203K ﹤0.01% 3590
2017
Q1
$456K Sell
32,500
-106,287
-77% -$1.51M ﹤0.01% 3944
2016
Q4
$2.21M Buy
138,787
+117,632
+556% +$1.89M ﹤0.01% 2815
2016
Q3
$351K Buy
21,155
+14,729
+229% +$198K ﹤0.01% 4218
2016
Q2
$72K Sell
6,426
-30,114
-82% -$292K ﹤0.01% 5342
2016
Q1
$305K Buy
36,540
+29,798
+442% +$245K ﹤0.01% 4672
2015
Q4
$63K Sell
6,742
-39,597
-85% -$395K ﹤0.01% 5755
2015
Q3
$523K Buy
46,339
+34,830
+303% +$426K ﹤0.01% 3698
2015
Q2
$146K Buy
11,509
+3,096
+37% +$33.4K ﹤0.01% 4707
2015
Q1
$78K Sell
8,413
-6,893
-45% -$77.9K ﹤0.01% 5217
2014
Q4
$219K Buy
15,306
+14,127
+1,198% +$167K ﹤0.01% 4610
2014
Q3
$12K Sell
1,179
-3,210
-73% -$42.1K ﹤0.01% 6180
2014
Q2
$71K Sell
4,389
-4,199
-49% -$55.9K ﹤0.01% 4912
2014
Q1
$140K Sell
8,588
-4,507
-34% -$64.1K ﹤0.01% 4679
2013
Q4
$162K Buy
13,095
+3,784
+41% +$38K ﹤0.01% 4850
2013
Q3
$102K Buy
9,311
+6,804
+271% +$72.7K ﹤0.01% 4708
2013
Q2
$21K Buy
+2,507
New +$16.9K ﹤0.01% 5810

Other funds holding VNDA